Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.

Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.

Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitiated methods for producing photoresist structures.

Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitiated methods for producing photoresist structures.

The present specification provides a compound having a spiro structure represented by the following Chemical Formula 1, and an organic light emitting device including the same: ##STR00001##
wherein R1 to R8, p, q, r, s, t, u, X and Y are defined therein.

The present specification provides a compound having a spiro structure represented by the following Chemical Formula 1, and an organic light emitting device including the same: ##STR00001##
wherein R1 to R8, p, q, r, s, t, u, X and Y are defined therein.

The present invention relates to compounds according to Formula (I): ##STR00001##
or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof wherein X.sup.1, X.sup.2, R.sup.1, R.sup.2, R.sup.3 and n are as defined herein. Also described are pharmaceutically acceptable compositions of Formula (I) compounds as well as methods for utilizing the compounds of Formula (I) and the pharmaceutically acceptable compositions of Formula (I) compounds as inhibitors of Mnk as well as therapeutics for the treatment of diseases such as cancer.

The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.

The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.

The present specification provides a compound having a spiro structure and an organic light emitting device including the same.